A carregar...

The role of rasagiline in the treatment of Parkinson’s disease

Parkinson’s disease (PD) is the second most common neurodegenerative disorder, affecting 1% to 2% of people older than 60 years. Treatment of PD consists of symptomatic therapies while neuroprotective strategies have remained elusive. Rasagiline is a novel, potent, and irreversible monoamine oxidase...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Leegwater-Kim, Julie, Bortan, Elena
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2877525/
https://ncbi.nlm.nih.gov/pubmed/20517484
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!